Sodium glycocholate liposome encapsulated semaglutide increases oral bioavailability [PMID: 39244070] Laboratory literature summary: Sodium glycocholate liposome encapsulated semaglutide increases oral bioavailability by promoting intestinal absorption
doi: 10.1016/S0140-6736(21)01324-6 Summary Keywords glucagon, GLP-1, obesity, co-agonist, weight loss Citation Hope DCD, Vincent ML and Tan TMM (2021) Striking the Balance: GLP-1/Glucagon Co-Agonism as a Treatment Strategy for Obesity
Heres my potentially not-so-controversial opinion: If youre even remotely considering plastic surgery, think of that as the first step to a lifestyle change
Our approach involves a personalized plan that combines GLP-1 receptor agonists with lifestyle modifications, including dietary adjustments and exercise
In some cases, such as a history of pancreatitis (inflammation of the pancreas), liver disease, or prior issues with alcohol, your provider may recommend avoiding alcohol altogether